Kaat Durinck

Journal Article
A1
open access

HTSplotter : an end-to-end data processing, analysis and visualisation tool for chemical and genetic in vitro perturbation screening

Carolina de Carvalho Nunes (UGent) , Jasper Anckaert (UGent) , Fanny De Vloed (UGent) , Jolien De Wyn, Kaat Durinck (UGent) , Jo Vandesompele (UGent) , Franki Speleman (UGent) and Vanessa Vermeirssen (UGent)

(2024) PLOS ONE. 19(1).

PhD Thesis

Exploring the PHF6-RRM2 axis as a novel entry point for targeted therapy in neuroblastoma using in vitro and in vivo modeling

Lisa Depestel (UGent)

(2023)

PhD Thesis

Preclinical evaluation of targeted therapeutic strategies for high-risk neuroblastoma

Carolina de Carvalho Nunes (UGent)

(2023)

Journal Article
A1
open access

Targeted AURKA degradation : towards new therapeutic agents for neuroblastoma

Muhammad Rishfi (UGent) , Simon Krols (UGent) , Fien Martens (UGent) , Sarah-Lee Bekaert (UGent) , Ellen Sanders (UGent) , Aline Eggermont (UGent) , Fanny De Vloed (UGent) , Joshua Robert Goulding (UGent) , Martijn Risseeuw (UGent) , Jan Molenaar, et al.

(2023) EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. 247.

Journal Article
A1
open access

Post‐operative minimal residual disease models to study metastatic relapse in soft‐tissue sarcoma patient‐derived xenografts

Suzanne Fischer (UGent) , David Creytens (UGent) , Sofie De Geyter (UGent) , Elly De Vlieghere (UGent) , Piet Pattyn (UGent) , Sarah-Lee Bekaert (UGent) , Kaat Durinck (UGent) , Nadine Van Roy (UGent) , An Hendrix (UGent) , Lore Lapeire (UGent) , et al.

(2023) CLINICAL AND TRANSLATIONAL MEDICINE. 13(6).

Conference Paper
C3
open access

Exploration of neuroblastoma xenograft models for the analysis of tumoral cell-free RNA in murine blood plasma

Jill Deleu (UGent) , Hanne Van Droogenbroeck (UGent) , Jasper Anckaert (UGent) , Jilke De Wilde (UGent) , Kaat Durinck (UGent) , Liselot Mus (UGent) , Justine Nuytens (UGent) , Muhammad Rishfi (UGent) , Kathleen Schoofs (UGent) , Franki Speleman (UGent) , et al.

(2023) Advances in Neuroblastoma Research (ANR) Meeting 2023, Abstracts.

Whole transcriptome profiling of liquid biopsies from tumour xenografted mouse models enables specific monitoring of tumour-derived extracellular RNA

Vanessa Vermeirssen (UGent) , Jill Deleu (UGent) , Annelien Morlion (UGent) , Celine Everaert (UGent) , Jilke De Wilde (UGent) , Jasper Anckaert (UGent) , Kaat Durinck (UGent) , Justine Nuytens (UGent) , Muhammad Rishfi (UGent) , Franki Speleman (UGent) , et al.

(2023)

Journal Article
A1
open access

Mitotic dysregulation at tumor initiation creates a therapeutic vulnerability to combination anti-mitotic and pro-apoptotic agents for MYCN-driven neuroblastoma

Lei Zhai, Anushree Balachandran, Rebecca Larkin, Janith A. Seneviratne, Sylvia A. Chung, Amit Lalwani, Shoma Tsubota, Dominik Beck, Kenji Kadomatsu, Anneleen Beckers (UGent) , et al.

(2023) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 24(21).

Journal Article
A2
open access

Exploration of neuroblastoma xenograft models for tumor extracellular RNA profiling in murine blood plasma

Jill Deleu (UGent) , Hanne Van Droogenbroeck (UGent) , Jasper Anckaert (UGent) , Anneleen Decock (UGent) , Jilke De Wilde (UGent) , Kaat Durinck (UGent) , Liselot Mus (UGent) , Justine Nuytens (UGent) , Muhammad Rishfi (UGent) , Kathleen Schoofs (UGent) , et al.

(2023) EXRNA. 5(2).

Research Data

Exploration of neuroblastoma xenograft models for tumor extracellular RNA profiling in murine blood plasma

Vanessa Vermeirssen (UGent) , Jill Deleu (UGent) , Annelien Morlion (UGent) , Celine Everaert (UGent) , Jilke De Wilde (UGent) , Jasper Anckaert (UGent) , Kaat Durinck (UGent) , Justine Nuytens (UGent) , Muhammad Rishfi (UGent) , Franki Speleman (UGent) , et al.

(2022)

Academic Bibliography

Kaat Durinck

Public URL

HTSplotter : an end-to-end data processing, analysis and visualisation tool for chemical and genetic in vitro perturbation screening

Exploring the PHF6-RRM2 axis as a novel entry point for targeted therapy in neuroblastoma using in vitro and in vivo modeling

Preclinical evaluation of targeted therapeutic strategies for high-risk neuroblastoma

Targeted AURKA degradation : towards new therapeutic agents for neuroblastoma

Post‐operative minimal residual disease models to study metastatic relapse in soft‐tissue sarcoma patient‐derived xenografts

Exploration of neuroblastoma xenograft models for the analysis of tumoral cell-free RNA in murine blood plasma

Whole transcriptome profiling of liquid biopsies from tumour xenografted mouse models enables specific monitoring of tumour-derived extracellular RNA

Mitotic dysregulation at tumor initiation creates a therapeutic vulnerability to combination anti-mitotic and pro-apoptotic agents for MYCN-driven neuroblastoma

Exploration of neuroblastoma xenograft models for tumor extracellular RNA profiling in murine blood plasma

Exploration of neuroblastoma xenograft models for tumor extracellular RNA profiling in murine blood plasma

Contents

Support

Contact